EUVIMEDEUVIMED entdecken
Crossref

Structure–Activity Relationships of a Novel Cyclic Hexapeptide That Exhibits Multifunctional Opioid Agonism and Produces Potent Antinociceptive Activity

Qinqin Zhang, Biao Xu, Dan Chen, Shuyuan Wu, Xuanran Hu, Xiaodi Zhang, Bowen Yu, Shichao Zhang, Zhenyun Yang, Mengna Zhang, Quan Fang iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.3c01347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Qinqin Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology, School of Basic Medical Sciences, and State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary M…. Hauptthemen laut MEDLINE: Analgesics, Opioid, Analgesics. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Foundation for Innovation Groups of Basic Research in Gansu Province, Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cyclic peptide c[d-Lys2, Asp5]-DN-9 has recently been identified as a multifunctional opioid/neuropeptide FF receptor agonist, displaying potent analgesic activity with reduced side effects. This study utilized Tyr-c[d-Lys-Gly-Phe-Asp]-d-Pro-NH2 (0), a cyclic hexapeptide derived from the opioid pharmacophore of c[d-Lys2, Asp5]-DN-9, as a chemical template. We designed, synthesized, and characterized 22 analogs of 0 with a single amino acid substitution to investigate its structure-activity relationship. Most of these cyclic hexapeptide analogs exhibited multifunctional activity at μ and δ opioid receptors (MOR and DOR, respectively) and produced antinociceptive effects following subcutaneous administration. The lead compound analog 15 showed potent agonistic activities at the MOR, κ opioid receptor (KOR), and DOR in vitro and produced a strong and long-lasting analgesic effect through peripheral MOR and KOR in the tail-flick test. Further biological evaluation identified that analog 15 did not cause significant side effects such as tolerance, withdrawal, or reward liability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidAnalgesicsStructure-Activity RelationshipReceptors, Opioid, kappaPeptides, CyclicReceptors, Opioid, mu

Substanzen

Analgesics, OpioidAnalgesicsReceptors, Opioid, kappaPeptides, CyclicReceptors, Opioid, mu

Autor:innen und Institutionen

  • Institute of Physiology, School of Basic Medical Sciences, and State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, 199 Donggang West Road, Lanzhou 730000, P…

ORCID-Profile: Quan Fang

Förderung

  • National Natural Science Foundation of China
  • Foundation for Innovation Groups of Basic Research in Gansu Province
  • Gansu Province
  • Gansu Basic Research

Zitieren

APA

Zhang, Q., Xu, B., Chen, D., Wu, S., Hu, X., Zhang, X., Yu, B., Zhang, S., Yang, Z., Zhang, M., & Fang, Q. (2024). Structure–Activity Relationships of a Novel Cyclic Hexapeptide That Exhibits Multifunctional Opioid Agonism and Produces Potent Antinociceptive Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01347

Vancouver

Zhang Q, Xu B, Chen D, Wu S, Hu X, Zhang X, et al. Structure–Activity Relationships of a Novel Cyclic Hexapeptide That Exhibits Multifunctional Opioid Agonism and Produces Potent Antinociceptive Activity. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.3c01347

BibTeX
@article{Zhang2024,
  author = {Zhang, Qinqin and Xu, Biao and Chen, Dan and Wu, Shuyuan and Hu, Xuanran and Zhang, Xiaodi and Yu, Bowen and Zhang, Shichao and Yang, Zhenyun and Zhang, Mengna and Fang, Quan},
  title = {Structure–Activity Relationships of a Novel Cyclic Hexapeptide That Exhibits Multifunctional Opioid Agonism and Produces Potent Antinociceptive Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.3c01347}
}
Kostenlos starten →